Real-time enrollment status for this lennox-gastaut syndrome clinical trial
Current Status
Active, Not Recruiting
Checked: July 19, 2026 at 5:59 AM UTC
| NCT Number | NCT06719141 |
| Recruiting Status | Active, Not Recruiting |
| Condition | Lennox-Gastaut Syndrome |
| Phase | PHASE3 |
| Target Enrollment | 320 participants |
| Active Locations | 31 sites in the US |
| Sponsor | Longboard Pharmaceuticals |
| Last Updated on CT.gov | July 17, 2026 (2 days ago) |
As of July 19, 2026: Clinical trial NCT06719141 is currently active_not_recruiting participants. This phase3 study for lennox-gastaut syndrome is not currently accepting new participants at 31 locations across the United States. The study is sponsored by Longboard Pharmaceuticals. This status information is automatically verified from the official ClinicalTrials.gov registry.
No, NCT06719141 is currently active_not_recruiting. The study may resume recruiting in the future.
This trial is recruiting at 31 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT06719141 was last updated 2 days ago (July 17, 2026). HelloStudys verifies this status automatically.